Warren Hogarth
Partner @ Sequoia Capital
San Francisco, United States
Warren Hogarth is a seed investor at Sequoia Capital in San Francisco focused on FinTech and Financial Services. Warren Hogarth is based out of London and is the Co-Founder and CEO of Tilt. Warren previously worked at Sequoia Capital as a Partner. Warren Hogarth attended the University of Queensland.
- Total investments:
- 24
- Last investment:
- Lead investor:
- 25%
Last updated:
For AI agents: llms.txt
Industries Warren Hogarth invests in
Stages Warren Hogarth invests in
Countries Warren Hogarth invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Seed
- $2.5M–$13M
- Series B
- $11M–$30M
- Series C
- $13M–$55M
Investment Focus
Industry
- FinTech 4 (17%)
- Financial Services 4 (17%)
- Finance 3 (13%)
- Energy 2 (8%)
- Health Care 2 (8%)
Stage
- Seed 4 (17%)
- Series B 4 (17%)
- Series C 4 (17%)
- Series A 3 (13%)
- Series D 2 (8%)
Country
- United States 8 (33%)
- Australia 2 (8%)
- Pakistan 1 (4%)
- New Zealand 1 (4%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Marloo is an AI-assistant that empowers financial advisers to focus on building client relationships, instead of paperwork. | $2.7M / Pre-Seed / Sep 08, 2025 | ||
| NayaPay is a digital platform that provides online transaction and banking services. | $13M / Seed / Feb 23, 2022 | ||
| Fable Food Co is a meat alternative company known for its meaty food made from mushrooms, which are clean label, minimally processed and made with all natural plant-based ingredients. The products are available in Harris Farm Markets, Coles and Woolworths, as well as Marley Spoon and Dinnerly meal delivery kits, and in various restaurant menusaround Australia, Singapore, and the UK. | $4.8M / Seed / Aug 12, 2021 | ||
| Great Question is a customer research platform designed to automate research tasks and gain consumer insights. Great Question allows its users to recruit participants, run their preferred methods, and synthesize and share their findings all in one collaborative platform. | $2.5M / Seed / Jul 14, 2021 | ||
| Celo is an open platform that makes financial tools accessible to anyone with a mobile phone. Its mission is to build a monetary system that creates the conditions of prosperity for all.The Celo ecosystem includes a decentralized, proof-of-stake blockchain technology stack (Celo Platform), a native asset (CELO), a stablecoin (cUSD) and the CeloAlliance for Prosperity, with over 100 organizations around the world, including Andreesen Horowitz, Anchorage, Coinbase, GSMA, Mercy Corps, Grameen Foundation, Prosegur, Abra, and cLabs, a service organization dedicated to growing and developing the Celo ecosystem. | $6.5M / Venture - Series Unknown / Jun 25, 2018 | ||
| Comprehend provides a suite of cloud applications and consulting services that improve the clinical trial process. Their solutions deliver actionable risk and performance insights across studies, systems, sites, and vendors. It was founded in 2010 and headquartered in Redwood City, California. | $15M / Series C / Feb 06, 2017 | ||
| Sunbit is a buy now, pay later technology of service providers and retailers fulfilling the needs of thousands of local communities. Sunbit eases the stress of buying everyday things by offering access to fast, fair, and transparent payment options to people across the credit spectrum. Sunbit technology is offered in-store and online through nearly7,300 locations, including 1 in 4 auto dealership service centers, optical practices, dentist offices, and specialty health care services. Payment options through Sunbit can be found at these establishments www.sunbit.com/shop-directoryLoans are made by Transportation Alliance Bank, Inc., dba TAB Bank, which determines qualifications for and terms of credit. | $2.9M / Seed / Sep 13, 2016 | ||
| Assurex Health is a personalized medicine company dedicated to helping clinicians determine the right medication for individual patients with medical conditions. Assurex Health’s proprietary Genesight® technology is based on pharmacogenomics – the study of the genetic factors that influence an individual’s response to drug treatments – as well asevidence-based medicine and clinical pharmacology. | $15M / Series D / Dec 21, 2015 | ||
| Guardant Health is committed to positively and significantly impacting patient health through technology breakthroughs that pointedly address long-standing unmet needs in oncology. Guardant is backed by Sequoia Capital, led by a seasoned management team comprising thought leaders and successful serial entrepreneurs in next-generation sequencing andrare-cell diagnostics and is closely advised by an oncologist-led medical steering committee from leading cancer centers across North America and abroad. | $50M / Series C / Feb 03, 2015 | ||
| Assurex Health is a personalized medicine company dedicated to helping clinicians determine the right medication for individual patients with medical conditions. Assurex Health’s proprietary Genesight® technology is based on pharmacogenomics – the study of the genetic factors that influence an individual’s response to drug treatments – as well asevidence-based medicine and clinical pharmacology. | $37.4M / Series D / Dec 23, 2014 | ||
| See all 24 investments → | |||
Co-Investors
About Sequoia Capital
Sequoia Capital provides capital alongside strategic guidance, supporting areas such as product development, company building, and market expansion. The firm engages with a limited number of companies at a time, working closely with leadership teams throughout the business lifecycle. Sequoia Capital focuses on long-term partnerships, often entering at the idea or formation stage and remaining involved as companies scale and mature. Its approach emphasizes collaboration among its internal team and portfolio founders, drawing on shared experience to address operational and strategic challenges.
Sequoia Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Anas Biad
Partner
|
|||
Andrew Lee
Vice President
|
|||
Carl Eschenbach
Partner
|
|||
Caroline Fu
Vice President
|
|||
Donald Valentine
Founder
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Warren Hogarth invest in?
Warren Hogarth invests primarily in FinTech, Financial Services and Finance startups, most often at Seed and Series B stage. Most of the 24 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Warren Hogarth invest in?
Warren Hogarth typically joins rounds of $2.5M–$13M at Seed, $11M–$30M at Series B and $13M–$55M at Series C. These are whole funding-round sizes, not Warren Hogarth's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Warren Hogarth took part in.
How do I contact Warren Hogarth?
Public channels for Warren Hogarth include LinkedIn, X (Twitter) and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Warren Hogarth last invest?
The most recent investment recorded for Warren Hogarth closed in Sep 2025. Shizune tracks 24 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
